Clinical Profile and Outcome of COVID-19 Among Immunocompromised Children

被引：0
|
作者：
Rao, Sunil Kumar [1 ]
Kumar, Ashutosh [1 ]
Prasad, Rajniti [1 ]
Gupta, Vineeta [1 ]
Mishra, Om Prakash [1 ]
机构：
[1] IMS BHU, Dept Pediat, Varanasi, Uttar Pradesh, India
来源：
INDIAN PEDIATRICS | 2021年 / 58卷 / 07期
关键词：
COVID-19; Children; Immunocompromised; Outcome;
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
This retrospective study describes the clinical profile, risk of infection and outcome of coronavirus disease-19 in immunocompromised children. It was found that children on immunosuppressant medication has 2.89 times increased risk of infection (P=0.01). Disease manifestation was asymptomatic (P=0.01) or mild with predominant gastrointestinal symptoms (P=0.02) without alteration in immunosuppressive treatment regime.
引用
收藏
页码：686 / 687
页数：2
相关论文
共 50 条
  • [31] CLINICAL PROFILE AND OUTCOME OF CHILDREN AGES 1 MONTH TO 18 YEARS WITH CRITICAL COVID-19 AT THE PHILIPPINE CHILDREN'S MEDICAL CENTER
    Deatras, M. D.
    Lorenzo, M. R.
    PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (11)
  • [32] Impact of the COVID-19 Pandemic on Rates of Cytomegalovirus Testing and Diagnosis Among Immunocompromised Children in the United States
    Jain, P.
    Basnet, S.
    Syed, S.
    Arakaki, B.
    Mues, K. E.
    Marcum, Z.
    Diaz-Decaro, J.
    SWISS MEDICAL WEEKLY, 2023, 153 : 20S - 20S
  • [33] Clinical profile, outcome and management of kidney disease in COVID-19 patients - a narrative review
    Vahdat, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (06) : 2188 - 2195
  • [34] Molnupiravir efficacy among immunocompromised patients with COVID-19: no proof of concept
    Dorra Guermazi
    Panos Arvanitis
    Dimitrios Farmakiotis
    Infection, 2023, 51 : 1593 - 1595
  • [35] Clinical Features of COVID-19 in Children
    Bal, Zumrut Sahbudak
    Kurugol, Zafer
    Ozkinay, Ferda
    JOURNAL OF PEDIATRIC RESEARCH, 2020, 7 (02) : 88 - 91
  • [36] Clinical Characteristics of Children with COVID-19
    Ho, Carmen Lok Tung
    Oligbu, Peter
    Ojubolamo, Olakunle
    Pervaiz, Muhammad
    Oligbu, Godwin
    AIMS PUBLIC HEALTH, 2020, 7 (02): : 258 - 273
  • [37] Clinical Course and Outcome of COVID-19 in Children With Biliary Atresia: A Retrospective Study
    Yang, Yifan
    Jiang, Jingying
    Zhou, Jin
    Wang, Shuxin
    Chen, Gong
    Zheng, Shan
    HEALTH SCIENCE REPORTS, 2025, 8 (02)
  • [38] Molnupiravir efficacy among immunocompromised patients with COVID-19: no proof of concept
    Guermazi, Dorra
    Arvanitis, Panos
    Farmakiotis, Dimitrios
    INFECTION, 2023, 51 (05) : 1593 - 1595
  • [39] Immunocompromised children and young people are at no increased risk of severe COVID-19
    Chappell, H.
    Patel, R.
    Driessens, C.
    Tarr, A. W.
    Irving, W. L.
    Tighe, P. J.
    Jackson, H. J.
    Harvey-Cowlishaw, T.
    Mills, L.
    Shaunak, M.
    Gbesemete, D.
    Leahy, A.
    Lucas, J. S.
    Faust, S. N.
    de Graaf, H.
    JOURNAL OF INFECTION, 2022, 84 (01) : 31 - 39
  • [40] INTRACTABLE COVID-19 INFECTION IN THE IMMUNOCOMPROMISED
    Amin, Muazzam
    Baig, Saqib
    CRITICAL CARE MEDICINE, 2024, 52
12345